CA2763941A1 — Compositions, methods & systems for respiratory delivery of two or more active agents
Assigned to Pearl Therapeutics Inc · Expires 2010-12-02 · 15y expired
What this patent protects
Compositions, meth-ods and systems are provided for pul-monary or nasal delivery of two or more active agents via a metered dose inhaler. In one embodiment, the com-positions include a suspension medi-um, active agent particles, and sus-pending particles, in which the active agen…
USPTO Abstract
Compositions, meth-ods and systems are provided for pul-monary or nasal delivery of two or more active agents via a metered dose inhaler. In one embodiment, the com-positions include a suspension medi-um, active agent particles, and sus-pending particles, in which the active agent particles and suspending parti-cles form a co-suspension within the suspension medium.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.